| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |